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Abstract 
Background: The incidence and characteristics of gastric cancer have been shown to vary widely 
across Western and Eastern countries. Our study had two aims: to evaluate long-term trends in 
gastric adenocarcinoma in Japan over a period of 70 years, and to anticipate the future of gastric 
cancer in Japan, through comparison with data from the United States.  
Methods: Japanese patient data for 19,306 incident cases of gastric adenocarcinoma from 1946 – 
2014 were collected from the Gastric Cancer Database at the Cancer Institute Hospital, Tokyo, 
Japan (CIH-GCDB). U.S. patient data for 78,625 incident cases of gastric cancer from 1973 - 2012 
were obtained from the National Cancer Institute’s Surveillance, Epidemiology, and End Results 
(SEER) database. Changes over time in patient and tumor characteristics were investigated in these 
two cohorts. 
Results: There was a marked reduction of cancer incidence in the lower third of the stomach in 
the CIH-GCDB; over 70% to around 30%. The incidence in the upper third has been increasing 
steadily over time; 3% to 19%, although the number of cardia tumors has not changed. An increase 
in elderly and obese patients was also noted. In the U.S. population, there was a significant 
difference in the primary site across races. A notable overall increase in cardia cancer was evident 
in the Western population during the study period, with no similar change evident in the Japanese 
population over the last 15 years. In the East Asian population, the proportional frequency of 
tumors in the cardia was lower and that of tumors in the pyloric antrum was higher.  
Conclusion: In Japan, cancer in the antrum or pylorus of the stomach has been declining, whereas 
cancer in the body has been increasing. Unlike the Western population in the United States, 
adenocarcinoma of esophago-gastric junction is not increasing in Japan. 
Key words: gastric cancer, primary site, long-term trend 
Background 
The incidence rates of gastric cancer have been 
shown to vary widely across countries (1,2). The 
highest incidence rates are in East Asia (particularly 
Japan, China, Mongolia and Korea) and some parts of 
South America, whereas the lowest rates are in North 
America. Over the last quarter of a century, there has 
been a steady decline in the age-adjusted incidence 








developed countries of North America and Europe 
(4,6,7) (Figure 1A). These trends may be attributable 
to a reduced intake of foods preserved by salting or 
smoking, and a reduction in the prevalence of H. 
pylori infection (8-10) through improvements in 
hygiene (3,9,11-14). However, a steady increase in the 
estimated number of new patients with gastric cancer 
has been observed in Japan with the rapid aging of 
society (Figure 1B) (15). 
Under these circumstances, the oncological 
characteristics of stomach cancer have been changing. 
Namely, the increasing incidence of adenocarcinoma 
in the cardia has been strongly associated with the 
increase of obesity and gastro-esophageal reflux 
disease followed by the development of Barrett’s 
esophagus in western countries (16-18). Under the 
influence of lifestyle “Westernization,” there are also 
concerns that a rapid increase of adenocarcinoma in 
the EGJ will become evident in the near future in East 
Asia (15,19,20), whereas cancer at the EGJ has 
remained rare (21-23). As some previous reports have 
noted, there are distinct differences in the primary site 
and biologic characteristics of gastric cancer between 
Asian patients and those from other racial and ethnic 
groups (24-26). Although some researchers have 
previously investigated differences in gastric cancer 
between white and black or Hispanic and non- 
Hispanic patients using national databases in the U.S. 
(25,27,28), few studies focused on the Asian 
population have been published recently. 
This present study was conducted to delineate 
the near future of gastric cancer in East Asia, through 
comparison of the long-term trends of gastric cancer 
subsites between Japanese patients and the East Asian 
population of a national database in the U.S. Our 
objectives were to provide relevant information that 
would allow clinicians to consider suitable treatment 
strategies and to guide planning of clinical research.  
 
 
Figure 1: Age-adjusted incident rate and death rate of Gastric cancer in Japan and the U.S. A: Age-adjusted incident rate of gastric cancer on Japanese 
and U.S. national statistics. Citation from Cancer Registry and Statistics, Cancer Information Service, National Cancer Center in Japan (6) and World Health 
Organization, GLOBOCAN 2012(7). B: Estimated number of new gastric cancer patients by gender in Japan. Citation from Cancer Registry and Statistics, Cancer 
Information Service, National Cancer Center in Japan (6) 






Data for Japanese patients were identified from 
the Gastric Cancer Database at the Cancer Institute 
Hospital, Tokyo, Japan (CIH-GCDB) (29). The 
database includes entries for 19,306 consecutive 
patients who were treated for gastric cancer between 
1946 and 2014 in the department of surgery at the 
institute. Patients who received only endoscopic 
resection or treated by the chemotherapy without any 
surgical interventions were originally excluded in 
CIH-GCDB. In addition, patients with histologically 
proven squamous cell carcinoma, adenosquamous 
carcinoma or non-epithelial tumors such as 
lymphoma, sarcoma and metastatic cancers from 
other primary neoplasms were excluded from the 
present analyses. Patient data were completely 
anonymized.  
Data for patients in the U.S. were obtained from 
the National Cancer Institute’s Surveillance, 
Epidemiology, and End Results (SEER) database. The 
SEER database is a population-based publicly 
available data set that has been gathering data since 
1973 and represents approximately 28% of all cancer 
cases in the U.S. After excluding histologically proven 
squamous cell carcinoma, sarcoma and lymphoma, a 
total of 78,625 patients who were diagnosed as having 
gastric cancer between 1973 and 2012 were enrolled. 
Because the data from both the SEER registry (http:// 
seer.cancer.gov/) and the CIH-GCDB (29) are 
de-identified and publicly available, no institutional 
review board approval was necessary for this study. 
Definition of the primary site 
There is a difference in primary tumor 
anatomical subsite classification between the two 
databases (Supplemental Figure 1). The tumor 
location data in SEER are coded using the 
International Classification of Diseases for Oncology, 
3rd edition (ICD-O-3) (30), whereas they are coded 
according to the classification of the Japanese Gastric 
Cancer Association (JGCA) (31) in the CIH-GCDB, 
being divided anatomically into three stomach 
regions, i.e. the upper, middle, and lower thirds 
defined by the lines connecting the trisected points on 
the lesser and greater curvatures. In addition, the area 
extending 2 cm above to 2 cm below the 
esophago-gastric junction (EGJ) is designated the EGJ 
area. Tumors having their epicenter in this area are 
designated as EGJ carcinomas. In order to account for 
the different anatomical subsite classifications across 
databases, we treated the “cardia” as synonymous 
with the “EGJ”, the “body and fundus” as synon-
ymous with the “upper third and middle third” and 
the “antrum and pylorus” as synonymous with the 
lower third in the JGCA data.  
Study variables 
Patient-level data, including gender, age at 
diagnosis, ethnicity, tumor primary site or location, 
tumor size, TNM staging and histology were 
identified from each of the CIH-GCDB and SEER 
databases. To investigate the shifts in tumor location 
over time, the proportional frequencies in the 
CIH-GCDB were calculated every ten years, and those 
in the SEER every five years. As potential 
confounders for the primary site, patient ages, gender 
and body mass index (BMI) were obtained for the 
Japanese population. The 7th edition of the American 
Joint Committee on Cancer (AJCC) TNM classification 
was used for tumor staging based on CIH-GCDB data, 
whereas tumor staging was made on the basis of the 
6th edition of the AJCC TNM staging system for part 
of the SEER database (from 2004 to 2012, n=18,092).  
Statistical analysis 
The descriptive statistics were evaluated with 
reference to the patients’ backgrounds and tumor 
characteristics and, as necessary, continuous variables 
were compared using Student’s t test and categorical 
variables by Fisher’s exact test. 
To estimate the odds ratio of adenocarcinoma 
occurring in the upper third of the stomach, logistic 
regression models were analyzed with the time 
period as a dependent variable and incidence of 
cancer in the upper third of the stomach as an 
independent variable. In addition, to compare time 
trends among white and black Americans, East Asian 
Americans (Japanese=4,320, Chinese=2,008 and 
Koreans=874) living in the US, and Japanese patients 
entered in the CIH-GCDB. All statistical tests were 
two-sided, and p values of 0.05 or less were 
considered to indicate statistical significance. All the 
analyses were performed with STATA version 11.1 
(Stata Corp, College Station, TX). 
Results 
Japanese population in the CIH-GCDB 
Table 1 shows the characteristics of the patients 
and their tumors in Japan. The mean patient age was 
59.0 years, and the proportion of males was 65.2%. 
Figure 2A shows the change over time in the 
proportion of tumors according to the primary site for 
every ten-year period from 1946 to 2014. There was a 
marked reduction of cancer incidence in the lower 
third of the stomach, whereas incidence in the upper 
third has been increasing steadily up to the present. 
The proportion of EGJ cancers was found not to have 
changed markedly during the observation period. On 




the basis of Figure 2A, we divided the study period 
into three parts: 1946 to 1974 as the early period, 1975 
to 1994 as the middle period, and 1995 to 2014 as the 
late period. Table 1 also shows the characteristics in 
each group. The mean age and BMI of patients at 
diagnosis has been increasing over time, but there 
have not been any significant changes in the gender 
ratio, histological types or cross-sectional position. 
Besides, the proportion of signet-ring cell carcinoma 
had been increasing from early to middle period. 
 
Table 1. Patients and tumor characteristics and the time trend in 
CIH-GCDB 
    All Patients   1946 to 1974   1975 to 1994   1995 to 2014   
(N = )  19,306  5,991  5,437  7,878  
    No. %   No. %   No. %   No. % p 
Age at treatment                        <.001 
  Mean   59.0    55.1    58.0    62.6    
  SD   12.0    11.1    11.9    11.6    
Gender                     0.029 
 Male  12,584 65.2   3,827 63.9   3,599 66.2   5,158 65.5   
  Female  6,702 34.7   2,164 36.1   1,838 33.8   2,700 34.3    
BMI (kg/m2)              
Mean  21.3  19.8   21.5   22.3   
SD  3.2  2.8   2.9   3.3   
Primary site*                        <.001 
  EGJ   1,160 6.0    457 7.6    351 6.5    352 4.5    
  Upper   2,571 13.3    401 6.7    762 14.0    1,388 17.6    
  Middle   8,229 42.6    2,102 35.1    2,621 48.2    3,506 44.5    
  Lower   6,843 35.4    2,927 48.9    1,565 28.8    2,351 29.8    
  Unclassified   503 2.6    104 1.7    138 2.5    281 3.6    
Tumor size (mm)                     <.001 
 Mean  56.4   68.8   55.3   48.5   
  SD  35.9   29.4   38.6   35.6    
Stage             <.001 
 IA  6,225 32.2   714 11.9   2,080 38.3   3,431 43.6   
 IB  1,483 7.7   283 4.7   451 8.3   749 9.5   
 IIA  1,466 7.6   563 9.4   353 6.5   550 7.0   
 IIB  1,557 8.1   630 10.5   416 7.7   511 6.5   
 IIIA  1,390 7.2   691 11.5   308 5.7   391 5.0   
 IIIB  1,428 7.4   699 11.7   356 6.5   373 4.7   
 IIIC  1,108 5.7   498 8.3   352 6.5   258 3.3   
 IV  3,072 15.9   1,304 21.8   754 13.9   1,014 12.9   
  Unknown  1,577 8.2   609 10.2   367 6.8   601 7.6    
Histological findings*                     <.001 
  tub/pap   7,989 41.4    2,650 44.2    2,284 42.0    3,055 38.8    
  poor   5,797 30.0    1,980 33.0    1,476 27.1    2,341 29.7    
  muc   482 2.5    182 3.0    133 2.4    167 2.1    
  sig   3,299 17.1    361 6.0    1,292 23.8    1,646 20.9    
  Unknown   32 0.2    6 0.1    2 0.0    24 0.3    
BMI; Body Mass Index, SD: Standard Deviation, EGJ: Esophago-gastric Junction,  
*; Descriptions according to the definition by Japanese Gastric Cancer Association 
 
Table 2. Independent risk factors for upper third gastric cancer in 
CIH-GCDB  
  Odds 
Ratio 
SE P-value  95% Confidential 
Interval 
Gender (Male/Female) 0.745  0.036  <0.001  0.678  - 0.818  
Time proceeds (per year)  1.019  0.016  <0.001  1.158  - 1.222  
Upper age (every 10 
years) 
1.082  0.020  <0.001  1.043  - 1.122  
Higher BMI(kg/m2) 1.036  0.007  <0.001  1.022  - 1.050  
BMI; Body Mass Index 
 
 
Figure 2B shows the changes in patient age over 
time, and BMI at diagnosis for each sex. Logistic 
regression analysis showed that gender (male), age 
(older), BMI (obese) and period (recent years) were 
significant independent risk factor for the incidence of 
upper third gastric cancer (Table 2). 
US population in the SEER database 
Table 3 shows the characteristics of the U.S. 
patients and their tumors. In this comparison between 
patients as a whole and the East Asian population, 
there was a significant difference only in the primary 
site, and there were no clear differences in the other 
items. In the East Asian population, the proportion of 
tumors in the cardia was lower (9.3%) and that of 
tumors in the pyloric antrum was higher (29.7%). 
Figure 3 shows the trend of the primary site for each 
of the white, black, and East Asian populations during 
this period. A notable increase of tumors in the cardia 
was evident in the white or black population during 
the study period overall, but no remarkable change 
was evident in the East Asian population over the last 
15 years.  
 
Table 3. Patients and tumor characteristic of All Patients and East 
Asian patients with gastric cancer in SEER database 
    All Patients   East Asian 
  (N = ) 78,625  (%)   7,202  (%) 
Diagnostic Year          
  1973-1982 18,875  24.0    1,232  17.1  
  1983-1992 19,847  25.2    1,793  24.9  
  1993-2002 19,852  25.2    2,123  29.5  
  2003-2012 20,051  25.5    2,054  28.5  
Race White 58,118  73.9    N.A. 
 Black 9,251  11.8   
 East Asian 7,202  9.2   
  Others 4,054  5.2    
Age at diagnosis (Year)          
  Mean 69.4   70.5 
  SD 15.7   13.5 
Gender        
 Male 48,541 61.7   4,241 58.9  
  Female 30,084 38.3    2,961 41.1  
Primary Site            
  Cardia 18,496 23.5    673 9.3  
  Fundus 3,270 4.2    189 2.6  
  Body 5,268 6.7    767 10.6  
  Pylorus or Antrum 16,490 21.0    2,361 32.8  
  Overlapping 17,380 22.1    2,061 28.6  
  NOS 17,721 22.5    1,151 16.0  
Tumor size (mm)          
 Mean 48.3  49.5 
  SD 44.8   43.7 
Histological findings          
  well differentiated 3,851 4.9    308 4.3  
  moderate 14,933 19.0    1,499 20.8  
  poor 33,644 42.8    3,494 48.5  
  others 2,922 3.7    158 2.2  
  Unknown 23,275 29.6    1,748 24.3  
TNM Stage AJCC 6th (Available data from 2004 to 2012)     
  (N = ) 18,092 (%)   1,840 (%) 
 0 182 1.0   27 1.5  
 IA 2,530 14.0   311 16.9  
 IB 1,713 9.5   198 10.8  
 II 1,899 10.5   194 10.5  
 IIIA 1,460 8.1   156 8.5  
 IIIB 324 1.8   46 2.5  
 IV 6,760 37.4   668 36.3  
  Unknown 3,224 17.8    240 13.0  
SD; Standard deviation, NOS; Not otherwise specified 
 





The main results of our study are threefold. First, 
in Japan, the incidence of gastric cancer in the lower 
third (antrum or pylorus) of the stomach has been 
steadily decreasing up to 1985, whereas that in the 
upper third excluding the EGJ has been steady 
increasing up to the present. Second, East Asians 
living in the United States showed a tumor location 
trend distinctly different from that of patients of other 
races living in the U.S.; their proportion of cardia 
cancers has not been increasing over last 15 years, 
unlike the trend for white and black patients. Lastly, 
in the Japanese population, older age, obesity, male 
gender and recent year of diagnosis were significant 
independent risk factors for upper third gastric 
cancer. 
Whereas the incidence rate of a lot 
of malignant neoplasms has been rising 
in developed countries, these of gastric, 
hepatic or uterine cervix cancer showed 
decline tendency (1,2,6,7). The principal 
reason has been thought to be attributed 
to improvements in general public 
health. Namely the etiology these 
neoplasms were strongly associated to 
prevalence of specific virus or bacterial 
infection, and the decreasing of incident 
rate and advances of hygienic enviro-
nment were observed in developed 
countries. Among environmental factors 
associated with the risk of gastric cancer, 
some researchers have regarded the 
endemic of H. pylori infection as one of 
the strongest carcinogenic factors 
(8,32,33). The sero-prevalence rate of H. 
pylori infection was approximately 40 to 
70% in patients with gastric cancer in 
Asian countries (34), and the overall 
sero-prevalence rate has been decreasing 
with the time trend (8,34,35). Improve-
ments in living conditions, the water 
supply or sewage systems are strongly 
correlated with the declining prevalence 
of H. pylori (34). The expansion of 
industrial refrigeration has reduced the 
need for salting and pickling for food 
preservation, and the development of 
transportation has allowed distribution 
of fresher products to consumers (3). It 
has also become easy for people to 
include potentially protective factors 
such as vitamins A, C, and E in their diet 
throughout the year (9-11), which may 
counteract carcinogenesis in the stomach 
linked to intake of N-nitroso compounds in smoked 
or grilled meat (36,37). The decline in the incidence of 
gastric cancer in Japan has been attributed to the 
overall improvement of public health accompanying 
the high economic growth following the severe 
poverty after World War II. Significantly, however, 
our results indicate that the above factors have been 
particularly associated with cancer in the antrum or 
pylorus of the stomach, rather than with gastric 
cancer as a whole. The number of patients with cancer 
in the upper third of the stomach has, in fact, been 
increasing over time, and therefore it can be 
considered that the risk factors for adenocarcinoma in 
the upper third are differ from those for cancer in the 
lower third. In term of histopathological type that has 
strong association with primary site arising 
adenocarcinoma, the fact that the proportion of signet 
 
Figure 2: Primary site, patients age and BMI in CIH-GCDB. A: Time trends of in the 
relative frequencies of cancers arising at each primary site, based on the CIH-GCDB data. B: Time 
trends in age and BMI of patients with gastric cancer by gender. 
 




ring cell carcinoma has been rapidly increasing from 
early to middle period was not inconsistent with this 
sift of cancer location (Table 1). 
From a physician’s viewpoint, the current trend 
suggests that in East Asian populations a larger 
number of patients will need to be treated for cancer 
in the upper third of the stomach as time passes. In 
addition, as the proportion of obese and elderly 
patients will continue to increase in the near future, 
treatment of gastric cancer may become more difficult 
than it has been in the past. In this connection, a 
crucial difference between Japanese 
and Western patients is that the 
incidence of adenocarcinoma at the 
EGJ has remained consistently low in 
Japan for the last 70 years. Despite the 
marked increase of EGJ adenocarcin-
oma in Western patients documented 
in the SEER data and previous studies, 
the proportion of EGJ cancer in East 
Asians in the SEER has remained 
consistently low. Considering the 
trends evident in the two databases, it 
seems unlikely that the incidence of 
adenocarcinoma in the EGJ will 
increase rapidly in East Asian countries 
as a result of westernization in the near 
future.  
This large-scale database study 
has some limitations. First, there is the 
difficulty in classifying adenocarcin-
oma as being present in the upper 
third, cardia or EGJ. In general, two 
types of adenocarcinoma can arise in 
the EGJ; one is derived from the fundic 
glands of the stomach, and the other 
from Barrett’s epithelium. These two 
cancers ought to be essentially disting-
uished from each other, i.e. upper 
gastric cancer with esophageal invasi-
on, and lower esophageal cancer with 
gastric invasion. However, in most 
cases, it is clinicopathologically diffic-
ult to identify whether the origin of a 
neoplasm is the gastric gland or the 
metaplastic columnar epithelium of the 
esophagus. Therefore, both gastric 
cancer with esophageal invasion and 
adenocarcinoma from Barrett’s esopha-
gus have been registered under the 
same category in all clinical databases. 
In addition, the Japanese definition of 
cancer in cardia is a slightly different 
from that of ICD-10 (Supplemental 
figure 1). Second, the SEER database 
contains no information about the lifestyle of the East 
Asian population, such as how long they have lived in 
the US or the types of foods they usually eat. 
Therefore, unknown or unmeasurable – but important 
– potential confounders might be overlooked. Anoth-
er problem is that there is no guarantee that patients 
entered in the CIH-GCDB are a representative sample 
of Japanese patients with gastric cancer. The CIH- 
GCDB is a database representing patients seen at a 
single institution, although the hospital handles the 
highest volume of cancer patients in Japan and the 
 
Figure 3: Time trends in the relative frequencies of cancers arising at each primary site, 
based on the SEER database. A: Time trend of proportional frequency for patients overall. B: 
Time trend of proportional frequency for Western (White or Black) patients overall. C: Time trend of 
proportional frequency for East Asian (Chinese, Korean and Japanese) patients 
 




registration system has been established for nearly 70 
years. The multi-center national cancer database 
system in Japan is still in its early stages and is tightly 
restricted to access for general researchers. Therefore, 
using the CIH-GCDB was the best resource for 
addressing our research aims, enabling us to analyze a 
large number of patients over a long time period. 
In conclusion, our findings suggest that cancer in 
the lower third of the stomach has been declining, 
whereas cancer in the upper third has been increasing 
in recent years in Japan. Unlike the situation in 
Western patients, currently there is no evidence of any 
increase of EGJ adenocarcinoma in the Japanese 
population. However, from a clinical viewpoint, it 
may become more difficult to treat gastric cancer in 
Japanese patients in comparison with the past, in view 
of the increase of elderly and obese patients 
presenting with adenocarcinoma in the upper third of 
the stomach. 
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